Mass Tort brief
Mass Tort Update: Settling Contraceptive Claims and Testing Device Defects
Pfizer reaches a sudden global settlement framework for Depo-Provera, while Indivior and Medtronic prepare for critical bellwether tests.
Mass Tort
Pfizer is moving quickly to cap its contraceptive liability — a sudden framework that preempts a public trial and reveals the massive financial risk of brain-tumor claims.
BackgroundDepo-Provera is an injectable contraceptive used by millions of women worldwide. The consolidated federal litigation includes over 5,800 active claims alleging that long-term use of the drug significantly increases the risk of developing meningioma brain tumors.
- Plaintiffs' attorneys are discussing individual payout estimates ranging from $75,000 to over $1.5M, establishing a high baseline for severity-adjusted neurological injury compensation.
- The global settlement structure effectively preempts the first bellwether trials, preventing public disclosures of internal company data that could damage Pfizer's corporate reputation.
- Pfizer's rapid pivot to settle highlights the significant financial risks of brain tumor claims, prompting other drugmakers to re-evaluate potential liabilities in product pipelines.
Mass Tort
Medtronic's hernia mesh is facing its first jury test in Massachusetts — a critical trial that will dictate the cost of settling thousands of pending surgical injury claims.
BackgroundHernia mesh devices are plastic or biological sheets surgically implanted to reinforce damaged muscle walls. Multidistrict litigations consolidate individual personal injury claims before a single judge to run test trials that steer broad settlement values.
- Plaintiff Larry Patterson alleges Covidien's Symbotex polyester-based mesh degraded inside his body, causing severe bowel obstructions that required partial bowel removal.
- Plaintiffs' counsel argued that Medtronic hid research showing its protective collagen barrier dissolves within 7 days, leaving the raw, abrasive mesh exposed to internal organs.
- Medtronic defended the safety profile of the Symbotex device, claiming the barrier is engineered to dissolve gradually as natural tissue healing takes over.
Mass Tort
Indivior's massive wave of tooth decay lawsuits is scaling past 18,000 cases — a rapid expansion that forces the drugmaker toward a multi-billion-dollar settlement.
BackgroundSuboxone is a sublingual film widely prescribed to treat opioid use disorder. Plaintiffs allege that the manufacturer failed to warn patients and doctors that the film's chemical formulation is highly acidic, causing permanent dental erosion.
- US District Judge J. Philip Calabrese is directing a medical verification phase to select 15 representative bellwether test cases, establishing the legal roadmap for the massive docket.
- Plaintiffs argue Indivior knew about the acidity risk for years but withheld warnings to protect its dominant market share, raising the threat of punitive damages during trial.
- Indivior faces multi-billion-dollar financial exposure as thousands of patients demand reimbursement for complex dental reconstruction surgeries and permanent physical disfigurement.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.